Browsing by Author "Shah, Suma"
Now showing items 1-5 of 5
-
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: Presentation and outcomes of adults at a single center.
Sutton, Paige; Lutz, Michael W; Hartsell, F Lee; Kimbrough, Dorlan; Tagg, N Troy; Skeen, Mark; Hudak, Nicholas M; ... (9 authors) (Journal of neuroimmunology, 2022-10)<h4>Background/introduction</h4>Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a chronic demyelinating disorder that has been increasingly recognized since the serum antibody became commercially ... -
Neuromyelitis optica: Clinical course and potential prognostic indicators.
Masha, Nidhila; Kimbrough, Dorlan J; Eckstein, Christopher P; Hudak, Nicholas M; Skeen, Mark B; Hartsell, F Lee; Lutz, Michael W; ... (8 authors) (Multiple sclerosis and related disorders, 2023-01)<h4>Background</h4>Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune neurological disorder associated with antibodies to aquaporin-4 (AQP4). NMOSD has been thought to follow a progressive disease course, ... -
Neurosarcoidosis following Immune Checkpoint Inhibition.
Dunn-Pirio, Anastasie M; Shah, Suma; Eckstein, Christopher (Case reports in oncology, 2018-05)Recently, immune checkpoint inhibitors have revolutionized cancer care by enhancing anti-tumor immunity. However, by virtue of stimulating the immune system, they can lead to immune-related adverse events (irAEs). Neurologic ... -
Nivolumab-Induced Autoimmune Encephalitis in Two Patients with Lung Adenocarcinoma.
Shah, Suma; Dunn-Pirio, Anastasie; Luedke, Matthew; Morgenlander, Joel; Skeen, Mark; Eckstein, Christopher (Case reports in neurological medicine, 2018-01)Immune checkpoint inhibitors have improved patient survival outcomes in a variety of advanced malignancies. However, they can cause a number of immune-related adverse effects (irAEs) through lymphocyte dysregulation. Central ... -
Women in neurology: A WIN-Win.
Shah, Suma (Annals of neurology, 2018-07-16)